240 related articles for article (PubMed ID: 34595994)
1. LncRNACASC9 promotes proliferation, metastasis, and cell cycle inovarian carcinoma cells through cyclinG1/TP53/MMP7 signaling.
Sun M; Chen Y; Liu X; Cui Y
Bioengineered; 2021 Dec; 12(1):8006-8019. PubMed ID: 34595994
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA (LncRNA) CASC9/microRNA(miR)-590-3p/sine oculis homeobox 1 (SIX1)/NF-κB axis promotes proliferation and migration in breast cancer.
Chang J; Zhang Y; Ye X; Guo H; Lu K; Liu Q; Guo Y
Bioengineered; 2021 Dec; 12(1):8709-8723. PubMed ID: 34711117
[TBL] [Abstract][Full Text] [Related]
3. LncRNA CASC9 promotes cell proliferation and invasion in osteosarcoma through targeting miR-874-3p/SOX12 axis.
Qiu H; Yang D; Li X; Feng F
J Orthop Surg Res; 2022 Oct; 17(1):460. PubMed ID: 36266695
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA CASC9 promotes LIN7A expression via miR-758-3p to facilitate the malignancy of ovarian cancer.
Hu X; Li Y; Kong D; Hu L; Liu D; Wu J
J Cell Physiol; 2019 Jul; 234(7):10800-10808. PubMed ID: 30537154
[TBL] [Abstract][Full Text] [Related]
5. DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression.
Wang LL; Sun KX; Wu DD; Xiu YL; Chen X; Chen S; Zong ZH; Sang XB; Liu Y; Zhao Y
J Cell Mol Med; 2017 Nov; 21(11):3055-3065. PubMed ID: 28598010
[TBL] [Abstract][Full Text] [Related]
6. Decreased long noncoding RNA ADIPOQ promoted cell proliferation and metastasis via miR-219c-3p/TP53 pathway in colorectal carcinoma.
Tang HQ; Meng YL; Lu QL; Dou YY; Liang LL; Luo Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7645-7654. PubMed ID: 32744690
[TBL] [Abstract][Full Text] [Related]
7. LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p.
Yao J; Fu J; Liu Y; Qu W; Wang G; Yan Z
Ann Hepatol; 2021; 23():100297. PubMed ID: 33346094
[TBL] [Abstract][Full Text] [Related]
8. MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression.
Yan J; Jiang JY; Meng XN; Xiu YL; Zong ZH
J Exp Clin Cancer Res; 2016 Feb; 35():31. PubMed ID: 26872615
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p.
Chen Y; Li Y; Gao H
Cancer Med; 2020 Mar; 9(5):1830-1841. PubMed ID: 31943867
[TBL] [Abstract][Full Text] [Related]
10. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
Zhang C; Li Y; Zhao W; Liu G; Yang Q
Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
[TBL] [Abstract][Full Text] [Related]
11. Long non‑coding RNA OIP5‑AS1 facilitates the progression of ovarian cancer via the miR‑128‑3p/CCNG1 axis.
Liu Y; Fu X; Wang X; Liu Y; Song X
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760168
[TBL] [Abstract][Full Text] [Related]
12. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p.
Xu C; Zhu LX; Sun DM; Yao H; Han DX
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1672-1681. PubMed ID: 32141533
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
Yang X; Xin N; Qu HJ; Wei L; Han Z
Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
[TBL] [Abstract][Full Text] [Related]
14. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling
Dai T; Liang J; Liu W; Zou Y; Niu F; Li M; Zhang H; Li C; Fan M; Cui G
Bioengineered; 2021 Dec; 12(2):10771-10781. PubMed ID: 34793263
[TBL] [Abstract][Full Text] [Related]
15. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA CASC9 promotes the progression and development of gastric cancer via regulating miR-370/EGFR axis.
Li C; Zhang J; Zhou Y; Li B
Dig Liver Dis; 2021 Apr; 53(4):509-516. PubMed ID: 33478874
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-134-3p inhibits ovarian cancer progression by targeting flap structure-specific endonuclease 1 in vitro.
Zhao M; Ji H; Fu Q; Cheng Q; Zhang Y; Yang Y
Oncol Rep; 2021 Jan; 45(1):119-128. PubMed ID: 33169800
[TBL] [Abstract][Full Text] [Related]
18. The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p.
Wang L; Ren C; Xu Y; Yang L; Chen Y; Zhu Y
J Ovarian Res; 2021 Jun; 14(1):77. PubMed ID: 34116704
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p.
Yang H; Qi Y; Wang XL; Gu JJ; Shi TM
Mol Cell Biochem; 2020 Apr; 467(1-2):95-105. PubMed ID: 32095930
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
